Nuclear lamins, diseases and aging

Current Opinion in Cell Biology

Volumn 18, Issue 3, 2006, Pages 335-341

  Mattout, Anna ^a   Dechat, Thomas ^b   Adam, Stephen A ^b   Goldman, Robert D ^b   Gruenbaum, Yosef ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LAMIN;

AGING; CELL NUCLEUS; CELL SHAPE; CELL STRUCTURE; CHROMATIN STRUCTURE; CONGESTIVE CARDIOMYOPATHY; DISEASE ASSOCIATION; DNA REPLICATION; GENE EXPRESSION; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; LIMB GIRDLE MUSCULAR DYSTROPHY; MUSCULAR DYSTROPHY; NONHUMAN; PRIORITY JOURNAL; PROGERIA; PROTEIN ASSEMBLY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; TRANSCRIPTION REGULATION; WERNER SYNDROME; XENOPUS;

AGING; AMINO ACID SEQUENCE; ANIMALS; CELL NUCLEUS; GENETIC DISEASES, INBORN; HUMANS; INTERMEDIATE FILAMENT PROTEINS; LAMIN TYPE A; LAMINS; MODELS, BIOLOGICAL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION;

EID: 33646536969     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ceb.2006.03.007     Document Type: Review

References (55)

1. Stuurman N., Heins S., and Aebi U. Nuclear lamins: their structure, assembly, and interactions. J Struct Biol 122 (1998) 42-66
2. Goldman R.D., Gruenbaum Y., Moir R.D., Shumaker D.K., and Spann T.P. Nuclear lamins: building blocks of nuclear architecture. Genes Dev 16 (2002) 533-547
3. Erber A., Riemer D., Hofemeister H., Bovenschulte M., Stick R., Panopoulou G., Lehrach H., and Weber K. Characterization of the hydra lamin and its gene: a molecular phylogeny of metazoan lamins. J Mol Evol 49 (1999) 260-271
4. Herrmann H., and Aebi U. Intermediate filaments: molecular structure, assembly mechanism, and integration into functionally distinct intracellular scaffolds. Annu Rev Biochem 73 (2004) 749-789
5. Corrigan D.P., Kuszczak D., Rusinol A.E., Thewke D.P., Hrycyna C.A., Michaelis S., and Sinensky M.S. Prelamin A endoproteolytic processing in vitro by recombinant Zmpste24. Biochem J 387 (2005) 129-138
6. Hennekes H., and Nigg E.A. The role of isoprenylation in membrane attachment of nuclear lamins. A single point mutation prevents proteolytic cleavage of the lamin A precursor and confers membrane binding properties. J Cell Sci 107 (1994) 1019-1029
7. Aebi U., Cohn J., Buhle L., and Gerace L. The nuclear lamina is a meshwork of intermediate-type filaments. Nature 323 (1986) 560-564
8. Strelkov S.V., Schumacher J., Burkhard P., Aebi U., and Herrmann H. Crystal structure of the human lamin A coil 2B dimer: implications for the head-to-tail association of nuclear lamins. J Mol Biol 343 (2004) 1067-1080. The crystal structure of the dimer coiled-coil of coil 2B from human lamin A at 2.2 Å resolution shows similar overall structure to vimentin. Mutations in this region that cause heritable disease are predicted to affect stages of filament assembly and lamina formation.
9. Karabinos A., Schunemann J., Meyer M., Aebi U., and Weber K. The single nuclear lamin of caenorhabditis elegans forms in vitro stable intermediate filaments and paracrystals with a reduced axial periodicity. J Mol Biol 325 (2003) 241-247
10. Harborth J., Elbashir S.M., Bechert K., Tuschl T., and Weber K. Identification of essential genes in cultured mammalian cells using small interfering RNAs. J Cell Sci 114 (2001) 4557-4565
11. Hutchison C.J., and Worman H.J. A-type lamins: guardians of the soma?. Nat Cell Biol 6 (2004) 1062-1067
12. Worman H.J., and Courvalin J.C. Nuclear envelope, nuclear lamina, and inherited disease. Int Rev Cytol 246 (2005) 231-279
13. •,43].
14. Muchir A., van Engelen B.G., Lammens M., Mislow J.M., McNally E., Schwartz K., and Bonne G. Nuclear envelope alterations in fibroblasts from LGMD1B patients carrying nonsense Y259X heterozygous or homozygous mutation in lamin A/C gene. Exp Cell Res 291 (2003) 352-362
15. Zastrow M.S., Vlcek S., and Wilson K.L. Proteins that bind A-type lamins: integrating isolated clues. J Cell Sci 117 (2004) 979-987
16. Agarwal A.K., Fryns J.P., Auchus R.J., and Garg A. Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia. Hum Mol Genet 12 (2003) 1995-2001
17. Taylor M.R., Slavov D., Gajewski A., Vlcek S., Ku L., Fain P.R., Carniel E., Di Lenarda A., Sinagra G., Boucek M.M., et al. Thymopoietin (lamina-associated polypeptide 2) gene mutation associated with dilated cardiomyopathy. Hum Mutat 26 (2005) 566-574
18. Gruenbaum Y., Margalit A., Shumaker D.K., and Wilson K.L. The nuclear lamina comes of age. Nat Rev Mol Cell Biol 6 (2005) 21-31
19. Gotzmann J., and Foisner R. A-type lamin complexes and regenerative potential: a step towards understanding laminopathic diseases?. Histochem Cell Biol 125 (2006) 33-41. An excellent review of all known models for laminopathies, which also suggests the adult cell differentiation model for explaining laminopathies.
20. Lammerding J., Schulze P.C., Takahashi T., Kozlov S., Sullivan T., Kamm R.D., Stewart C.L., and Lee R.S. Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction. J Clin Invest 113 (2004) 370-378. Evidence that lmna-null mouse embryo fibroblasts have deformed nuclei, impaired viability under mechanical stress, defective mechanotransduction and attenuated gene expression responses to mechanical stress via the NFκB signaling pathway.
21. Broers J.L., Peeters E.A., Kuijpers H.J., Endert J., Bouten C.V., Oomens C.W., Baaijens F.P., and Ramaekers F.C. Decreased mechanical stiffness in LMNA-/- cells is caused by defective nucleo-cytoskeletal integrity: implications for the development of laminopathies. Hum Mol Genet 13 (2004) 2567-2580
22. Favreau C., Dubosclard E., Ostlund C., Vigouroux C., Capeau J., Wehnert M., Higuet D., Worman H.J., Courvalin J.C., and Buendia B. Expression of lamin A mutated in the carboxyl-terminal tail generates an aberrant nuclear phenotype similar to that observed in cells from patients with dunnigan-type partial lipodystrophy and emery-dreifuss muscular dystrophy. Exp Cell Res 282 (2003) 14-23
23. Starr D.A., and Han M. ANChors away: an actin based mechanism of nuclear positioning. J Cell Sci 116 (2003) 211-216
24. Wilhelmsen K., Litjens S.H., Kuikman I., Tshimbalanga N., Janssen H., van den Bout I., Raymond K., and Sonnenberg A. Nesprin-3, a novel outer nuclear membrane protein, associates with the cytoskeletal linker protein plectin. J Cell Biol 171 (2005) 799-810
25. Cohen M., Lee K.K., Wilson K.L., and Gruenbaum Y. Transcriptional repression, apoptosis, human disease and the functional evolution of the nuclear lamina. Trends Biochem Sci 26 (2001) 41-47
26. Goldman R.D., Shumaker D.K., Erdos M.R., Eriksson M., Goldman A.E., Gordon L.B., Gruenbaum Y., Khuon S., Mendez M., Varga R., et al. Accumulation of mutant lamin A causes progressive changes in nuclear architecture in hutchinson-gilford progeria syndrome. Proc Natl Acad Sci USA 101 (2004) 8963-8968. Fibroblasts from Hutchinson-Gilford progeria patients show early senescence. Dramatic changes in nuclear structure, loss of peripheral heterochromatin and changes in nuclear envelope composition are observed. These changes can be also observed in normal cells that express LAΔ50.
27. Sullivan T., Escalente-Alcalde D., Bhatt H., Anver M., Naryan B., Nagashima K., Stewart C.L., and Burke B. Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J Cell Biol 147 (1999) 913-920
28. Nikolova V., Leimena C., McMahon A.C., Tan J.C., Chandar S., Jogia D., Kesteven S.H., Michalicek J., Otway R., Verheyen F., et al. Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A/C-deficient mice. J Clin Invest 113 (2004) 357-369
29. Scaffidi P., and Misteli T. Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome. Nat Med 11 (2005) 440-445. Inhibition of progerin expression in HGPS fibroblasts by different antisense oligonucleotides causes reversal of all detectable cellular phenotypes. Similar observations appear in [36].
30. Columbaro M., Capanni C., Mattioli E., Novelli G., Parnaik V.K., Squarzoni S., Maraldi N.M., and Lattanzi G. Rescue of heterochromatin organization in Hutchinson-Gilford progeria by drug treatment. Cell Mol Life Sci 62 (2005) 2669-2678
31. Filesi I., Gullotta F., Lattanzi G., D'Apice M.R., Capanni C., Nardone A.M., Columbaro M., Scarano G., Mattioli E., Sabatelli P., et al. Alterations of nuclear envelope and chromatin organization in mandibuloacral dysplasia, a rare form of laminopathy. Physiol Genomics 23 (2005) 150-158
32. Favreau C., Higuet D., Courvalin J.C., and Buendia B. Expression of a mutant lamin A that causes emery-dreifuss muscular dystrophy inhibits in vitro differentiation of C2C12 myoblasts. Mol Cell Biol 24 (2004) 1481-1492. Evidence that expression of EDMD mutations in myoblasts prevents these cells from differentiating in vitro into mature muscle cells. Similar observations also appear in reference [33].
33. Markiewicz E., Ledran M., and Hutchison C.J. Remodelling of the nuclear lamina and nucleoskeleton is required for skeletal muscle differentiation in vitro. J Cell Sci 118 (2005) 409-420
34. Eriksson M., Brown W.T., Gordon L.B., Glynn M.W., Singer J., Scott L., Erdos M.R., Robbins C.M., Moses T.Y., Berglund P., et al. Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature 423 (2003) 293-298
35. Chen L., Lee L., Kudlow B.A., Dos Santos H.G., Sletvold O., Shafeghati Y., Botha E.G., Garg A., Hanson N.B., Martin G.M., et al. LMNA mutations in atypical werner's syndrome. Lancet 362 (2003) 440-445
36. Huang S., Chen L., Libina N., Janes J., Martin G.M., Campisi J., and Oshima J. Correction of cellular phenotypes of Hutchinson-Gilford progeria cells by RNA interference. Hum Genet 118 (2005) 444-450
37. •] demonstrate that the farnesylated lamin A is toxic to cells and suggest a possible therapeutic treatment.
38. •].
39. •].
40. •].
41. •].
42. Capanni C., Mattioli E., Columbaro M., Lucarelli E., Parnaik V.K., Novelli G., Wehnert M., Cenni V., Maraldi N.M., Squarzoni S., et al. Altered pre-lamin A processing is a common mechanism leading to lipodystrophy. Hum Mol Genet 14 (2005) 1489-1502
43. Navarro C., De Sandre-Giovannoli A., Bernard R., Boccaccio I., Boyer A., Genevieve D., Hadj-Rabia S., Gaudy-Marqueste C., Smith H.S., Vabres P., et al. Lamin A and ZMPSTE24 (FACE-1) defects cause nuclear disorganisation and identify restrictive dermopathy as a lethal neonatal laminopathy. Hum Mol Genet 13 (2004) 2493-2503
44. Pendas A.M., Zhou Z., Cadinanos J., Freije J.M., Wang J., Hultenby K., Astudillo A., Wernerson A., Rodriguez F., Tryggvason K., et al. Defective prelamin A processing and muscular and adipocyte alterations in Zmpste24 metalloproteinase-deficient mice. Nat Genet 31 (2002) 94-99
45. Bergo M.O., Gavino B., Ross J., Schmidt W.K., Hong C., Kendall L.V., Mohr A., Meta M., Genant H., Jiang Y., et al. Zmpste24 deficiency in mice causes spontaneous bone fractures, muscle weakness, and a prelamin A processing defect. Proc Natl Acad Sci USA 99 (2002) 13049-13054
46. Varela I., Cadinanos J., Pendas A.M., Gutierrez-Fernandez A., Folgueras A.R., Sanchez L.M., Zhou Z., Rodriguez F.J., Stewart C.L., Vega J.A., et al. Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation. Nature 437 (2005) 564-568
47. Liu B., Wang J., Chan K.M., Tjia W.M., Deng W., Guan X., Huang J.D., Li K.M., Chau P.Y., Chen D.J., et al. Genomic instability in laminopathy-based premature aging. Nat Med 11 (2005) 780-785
48. Haithcock E., Dayani Y., Neufeld E., Zahand A.J., Feinstein N., Mattout A., Gruenbaum Y., and Liu J. Age-related changes of nuclear architecture in caenorhabditis elegans. Proc Natl Acad Sci USA 102 (2005) 16690-16695. Motivated by alterations observed in HGPS fibroblasts, this study demonstrates that distinct progressive and stochastic changes in nuclear architecture of C. elegans occur during the normal aging process of this organism, primarily in non-neuronal cells including muscle and intestinal cells. These changes are influenced by mutations in the insulin/IGF-1-like signaling pathway.
49. Guarente L., and Kenyon C. Genetic pathways that regulate ageing in model organisms. Nature 408 (2000) 255-262
50. Paradisi M., McClintock D., Boguslavsky R.L., Pedicelli C., Worman H.J., and Djabali K. Dermal fibroblasts in Hutchinson-Gilford progeria syndrome with the lamin A G608G mutation have dysmorphic nuclei and are hypersensitive to heat stress. BMC Cell Biol 6 (2005) 27
51. Taniura H., Glass C., and Gerace L. A chromatin binding site in the tail domain of nuclear lamins that interacts with core histones. J Cell Biol 131 (1995) 33-44
52. Fong L.G., Ng J.K., Lammerding J., Vickers T.A., Meta M., Cote N., Gavino B., Qiao X., Chang S.Y., Young S.R., et al. Prelamin A and lamin A appear to be dispensable in the nuclear lamina. J Clin Invest 116 (2006) 743-752
53. Varga R., Eriksson M., Erdos M.R., Olive M., Harten I., Kolodgie F., Capell B.C., Cheng J., Faddah D., Perkins S., et al. Progressive vascular smooth muscle cell defects in a mouse model of Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci USA 103 (2006) 3250-3255
54. McClintock D., Gordon L.B., and Djabali K. Hutchinson-Gilford progeria mutant lamin A primarily targets human vascular cells as detected by an anti-Lamin A G608G antibody. Proc Natl Acad Sci USA 103 (2006) 2154-2159
55. Tsai M.Y., Wang S., Heidinger J., Shumaker D., Adam S.A., Goldman R.D., and Zheng Y. A mitotic lamin B-matrix induced by RanGTP required for spindle assembly. Science 311 (2006) 1887-1893. This study demonstrates for the first time a direct role for the nuclear lamins in mitosis. Specifically, lamin B is required for the formation of a mitotic spindle matrix and for the association of several SAFs with this matrix. Both events are essential for the assembly of a functional mitotic spindle.